Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
04/17/2023 | Calithera Biosciences, Inc. | CALA | Other (disposition) | Series A Convertible Preferred Stock | 1000k | $0.00 | $0 | See Explanation of Responses | 04/17/2023 |
11/30/2022 | HilleVax, Inc. | | Exercise (in-the-money or at-the-money) | Common Stock | 5.9M | $0.00 | $0 | See Explanation of Responses | 11/30/2022 |
11/30/2022 | HilleVax, Inc. | | Exercise (in-the-money or at-the-money) | Warrant (Right to Buy) | 5.9M | $0.00 | $588.4 | See Explanation of Responses | 11/30/2022 |
07/01/2022 | Ovid Therapeutics Inc. | OVID | Other (acquisition) | Common Stock | 5.8M | $0.00 | $0 | See Explanation of Responses | 07/01/2022 |
07/01/2022 | Calithera Biosciences, Inc. | CALA | Other (disposition) | Series A Convertible Preferred Stock | 1000k | $0.00 | $0 | See Explanation of Responses | 07/01/2022 |
07/01/2022 | Calithera Biosciences, Inc. | CALA | Other (acquisition) | Series A Convertible Preferred Stock | 1000k | $0.00 | $0 | See Explanation of Responses | 07/01/2022 |
07/01/2022 | Ovid Therapeutics Inc. | OVID | Other (disposition) | Series A Convertible Preferred Stock | 1.2k | $0.00 | $0 | See Explanation of Responses | 07/01/2022 |
07/01/2022 | Ovid Therapeutics Inc. | OVID | Other (acquisition) | Series A Convertible Preferred Stock | 1.2k | $0.00 | $0 | See Explanation of Responses | 07/01/2022 |
03/14/2022 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 18 | $19.00 | $342 | | 03/14/2022 |
03/14/2022 | Phathom Pharmaceuticals, Inc. | PHAT | Exercise (in-the-money or at-the-money) | Warrants | 7.4M | $0.00 | $0 | | 03/14/2022 |
12/08/2021 | Day One Biopharmaceuticals, Inc. | | Sale | Common Stock | 110.3k | $18.03 | $2M | See Explanation of Responses | 12/07/2021 |
12/07/2021 | Day One Biopharmaceuticals, Inc. | | Sale | Common Stock | 58.2k | $19.50 | $1.1M | See Explanation of Responses | 12/07/2021 |
12/07/2021 | Day One Biopharmaceuticals, Inc. | | Sale | Common Stock | 128.7k | $18.43 | $2.4M | See Explanation of Responses | 12/07/2021 |
12/06/2021 | Day One Biopharmaceuticals, Inc. | | Sale | Common Stock | 97.7k | $18.05 | $1.8M | See Explanation of Responses | 12/03/2021 |
12/03/2021 | Day One Biopharmaceuticals, Inc. | | Sale | Common Stock | 12.5k | $18.47 | $231.2k | See Explanation of Responses | 12/03/2021 |
11/24/2021 | Day One Biopharmaceuticals, Inc. | | Other (acquisition) | Common Stock | 57.2k | $0.00 | $0 | See Explanation of Responses | 11/24/2021 |
11/04/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 1 | $19.00 | $19 | | 11/04/2021 |
11/04/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 1000k | $20.85 | $20.8M | | 11/04/2021 |
11/04/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Exercise (in-the-money or at-the-money) | Warrants | 228.7k | $0.00 | $0 | | 11/04/2021 |
10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Series C Preferred Stock | 226.9k | $0.00 | $0 | See explanation | 10/26/2021 |
10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Common Stock | 1.5M | $0.00 | $0 | See explanation | 10/26/2021 |
10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Series B Preferred Stock | 1.2M | $0.00 | $0 | See explanation | 10/26/2021 |
10/12/2021 | Theseus Pharmaceuticals, Inc. | THRX | Conversion | Series A Preferred Stock | 1.6M | $0.00 | $0 | See explanation | 10/12/2021 |
10/12/2021 | Theseus Pharmaceuticals, Inc. | THRX | Conversion | Common Stock | 1.6M | $0.00 | $0 | See explanation | 10/12/2021 |
07/07/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 2.6k | $35.05 | $91.4k | | 07/07/2021 |
07/02/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 100 | $35.01 | $3.5k | | 07/01/2021 |
07/01/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 8.2k | $35.16 | $289.2k | | 07/01/2021 |
06/28/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 370 | $35.08 | $13k | | 06/25/2021 |
06/25/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 1.2k | $36.07 | $45.1k | | 06/25/2021 |
06/25/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 22.9k | $35.46 | $811.4k | | 06/25/2021 |
06/24/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 10.8k | $35.14 | $381.2k | | 06/23/2021 |
06/23/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 200 | $35.00 | $7k | | 06/23/2021 |
06/22/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 100 | $35.00 | $3.5k | | 06/21/2021 |
06/21/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 9.3k | $35.31 | $328.2k | | 06/21/2021 |
06/18/2021 | Phathom Pharmaceuticals, Inc. | PHAT | Sale | Common Stock | 5.4k | $35.13 | $189.6k | | 06/17/2021 |
|